Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Negative Surgical Margins”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01826877
What this trial is testing

Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
Jonsson Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT01553539
What this trial is testing

Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery

Who this might be right for
Bone CancerChondrosarcomaClear Cell Sarcoma of the Kidney+9 more
Wake Forest University Health Sciences 20
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Not applicableStudy completedNCT06730412
What this trial is testing

CtDNA Liquid Biopsy for Early Assessment of Residual Disease in HPV-associated Head and Neck Cancer (Clear-HPVca)

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Massachusetts Eye and Ear Infirmary 103
Early research (Phase 1)Study completedNCT04504669
What this trial is testing

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more
AstraZeneca 60
Testing effectiveness (Phase 2)UnknownNCT03405454
What this trial is testing

A Multicentre Phase II Trial of Durvalumab Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas

Who this might be right for
Ovarian Clear Cell Carcinoma
National University Hospital, Singapore 46
Not applicableStudy completedNCT02579837
What this trial is testing

CLEAR SIGHT: A Trial of Non-Mydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease

Who this might be right for
Diabetes MellitusDiabetic Retinopathy
Western University, Canada 742
Testing effectiveness (Phase 2)Study completedNCT01108445
What this trial is testing

Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced Non-clear Cell Renal Cell Carcinoma
Duke University 131
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)UnknownNCT03341845
What this trial is testing

Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC

Who this might be right for
Renal Cell Carcinoma
The Netherlands Cancer Institute 40
Early research (Phase 1)Active Not RecruitingNCT03618381
What this trial is testing

EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+13 more
Seattle Children's Hospital 44
Testing effectiveness (Phase 2)Ended earlyNCT02059265
What this trial is testing

Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaOvarian Clear Cell CystadenocarcinomaRecurrent Fallopian Tube Carcinoma+3 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT01164228
What this trial is testing

Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney Cancer
ECOG-ACRIN Cancer Research Group 87
Testing effectiveness (Phase 2)Active Not RecruitingNCT05220267
What this trial is testing

Anlotinib Plus Sintilimab as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma

Who this might be right for
Non Clear Cell Renal Carcinoma
Sun Yat-sen University 44
Not applicableStudy completedNCT01890499
What this trial is testing

Prospective Controlled Trial On Clear Feeds Versus Low Residue Diet After Surgery In Elective Colorectal Surgery Patients

Who this might be right for
Nausea/Vomiting
Cedars-Sinai Medical Center 104
Testing effectiveness (Phase 2)Looking for participantsNCT05768464
What this trial is testing

Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors

Who this might be right for
Non-clear Renal Cell Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Testing effectiveness (Phase 2)Study completedNCT00059787
What this trial is testing

Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+6 more
National Cancer Institute (NCI) 56
Not applicableStudy completedNCT00815425
What this trial is testing

Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (The CLEAR Registry)

Who this might be right for
Rheumatoid Arthritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 1,613
Not applicableStudy completedNCT05432947
What this trial is testing

68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 42
Early research (Phase 1)Active Not RecruitingNCT04483778
What this trial is testing

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more
Seattle Children's Hospital 68
Next Page